がん治療を目指すアフェレシス

Saved in:
Bibliographic Details
Published inJinko Zoki Vol. 46; no. 3; pp. 180 - 182
Main Authors 寺本, 和雄, 小笠原, 一誠, 上田, 祐二
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本人工臓器学会 2017
JAPANESE SOCIETY FOR ARTIFICIAL ORGANS
Online AccessGet full text
ISSN0300-0818
1883-6097
DOI10.11392/jsao.46.180

Cover

Author 上田, 祐二
小笠原, 一誠
寺本, 和雄
Author_FL TERAMOTO Kazuo
UEDA Yuji
OGASAWARA Kazumasa
Author_FL_xml – sequence: 1
  fullname: TERAMOTO Kazuo
– sequence: 2
  fullname: UEDA Yuji
– sequence: 3
  fullname: OGASAWARA Kazumasa
Author_xml – sequence: 1
  fullname: 寺本, 和雄
  organization: 滋賀医科大学病理学講座疾患制御病理学
– sequence: 1
  fullname: 小笠原, 一誠
  organization: 滋賀医科大学病理学講座疾患制御病理学
– sequence: 1
  fullname: 上田, 祐二
  organization: 西日本旅客鉄道株式会社大阪鉄道病院
BackLink https://cir.nii.ac.jp/crid/1390001204963578752$$DView record in CiNii
BookMark eNo9kD1LA0EYhBeJYIzp_AlWwsV3bz_u3UaQ4BcEbLReNnt7ekdM5C6NZTaFTSrFItjZ2IiFjYg_ZyH5G16I2MwU8zAws00aw9HQEbJLoUMpU_FBUZlRh8sORdggTYrIIgkqaZAmMIAIkOIWaVdV3geBXDEKokn2w2QW_NPi82c598E_Ll8-FrOHMJkH_xqmz8G_hel78F_Bf--QzcwMKtf-8xa5Ojm-7J5FvYvT8-5RLypiQeOoLy1FDgoTi2lCWQYyU5ZJoXim0lQiSMHQpBg7JnhCXeb63FjMKKDhVLIW2Vv3DvNc23yl9T4AoDFwJZlIMBFxjR2usaIam2un78r81pT32pTj3A6cXt2hudRsJfUn_4G9MaUuDPsFJoJmcA
ContentType Journal Article
Copyright 2017 一般社団法人 日本人工臓器学会
Copyright_xml – notice: 2017 一般社団法人 日本人工臓器学会
DBID RYH
DOI 10.11392/jsao.46.180
DatabaseName CiNii Complete
DeliveryMethod fulltext_linktorsrc
EISSN 1883-6097
EndPage 182
ExternalDocumentID 130006507362
article_jsao_46_3_46_180_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
2WC
RYH
ID FETCH-LOGICAL-j2512-b6c1840987c8d713f06f9c36594f9dd6806538ad82e35471efeb4ac8f108a4163
ISSN 0300-0818
IngestDate Thu Jun 26 22:46:13 EDT 2025
Wed Sep 03 06:29:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2512-b6c1840987c8d713f06f9c36594f9dd6806538ad82e35471efeb4ac8f108a4163
OpenAccessLink https://www.jstage.jst.go.jp/article/jsao/46/3/46_180/_article/-char/ja
PageCount 3
ParticipantIDs nii_cinii_1390001204963578752
jstage_primary_article_jsao_46_3_46_180_article_char_ja
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle Jinko Zoki
PublicationTitleAlternate 人工臓器
PublicationTitle_FL Jpn. j. artif. Organs
人工臓器
JJAO
The Japanese Journal of Artificial Organs
PublicationYear 2017
Publisher 一般社団法人 日本人工臓器学会
JAPANESE SOCIETY FOR ARTIFICIAL ORGANS
Publisher_xml – name: 一般社団法人 日本人工臓器学会
– name: JAPANESE SOCIETY FOR ARTIFICIAL ORGANS
References 1) Tani T, Kodama M, Oka T, et al: Efficacy and biocompatibility of a novel anti-cancer fiber in hemoperfusion on cancer-bearing rabbits. Trans Am Soc Artif Intern Organs 30: 308-12, 1984
2) Numa K, Tani T, Kodama M: Trial of anticancer immunotherapy with immobilized pokewood mitogen: immunotherapy by extracorporeal circulation. Cancer Immunol Immunother 32: 125-30, 1990
3) Terman DS, Young JB, Shearer WT, et al: Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A. N Engl J Med 305: 1195-200, 1981
6) Nakamura K, Kitani A, Strober W: Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194: 629-44, 2001
10) Gabriely G, da Cunha AP, Rezende RM, et al: Targeting latency-associated peptide promotes antitumor immunity. Sci Immunol 2: pii: eaaj1738, 2017
5) Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-61, 2003
9) Kurose K, Ohue Y, Wada H, et al: Phase ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 Antibody, KW-0761, in cancer patients. Clin Cancer Res 21: 4327-36, 2015
8) Zaretsky ZM, Garcia-Diaz A, Shin DS, et al: Mutations associated with acquired resistance to PD-1 blockade in melanoma. N Engl J Med 375: 819-29, 2016
7) Rosenberg SA: IL-2: the first effective immunotherapy for human cancer. J Immunol 192: 5451-8, 2014
4) Yamamoto Y, Ueda Y, Itoh T, et al: A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats. Oncol Rep 16: 1277-84, 2006
References_xml – reference: 1) Tani T, Kodama M, Oka T, et al: Efficacy and biocompatibility of a novel anti-cancer fiber in hemoperfusion on cancer-bearing rabbits. Trans Am Soc Artif Intern Organs 30: 308-12, 1984
– reference: 6) Nakamura K, Kitani A, Strober W: Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194: 629-44, 2001
– reference: 9) Kurose K, Ohue Y, Wada H, et al: Phase ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 Antibody, KW-0761, in cancer patients. Clin Cancer Res 21: 4327-36, 2015
– reference: 2) Numa K, Tani T, Kodama M: Trial of anticancer immunotherapy with immobilized pokewood mitogen: immunotherapy by extracorporeal circulation. Cancer Immunol Immunother 32: 125-30, 1990
– reference: 4) Yamamoto Y, Ueda Y, Itoh T, et al: A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats. Oncol Rep 16: 1277-84, 2006
– reference: 3) Terman DS, Young JB, Shearer WT, et al: Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A. N Engl J Med 305: 1195-200, 1981
– reference: 8) Zaretsky ZM, Garcia-Diaz A, Shin DS, et al: Mutations associated with acquired resistance to PD-1 blockade in melanoma. N Engl J Med 375: 819-29, 2016
– reference: 10) Gabriely G, da Cunha AP, Rezende RM, et al: Targeting latency-associated peptide promotes antitumor immunity. Sci Immunol 2: pii: eaaj1738, 2017
– reference: 5) Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-61, 2003
– reference: 7) Rosenberg SA: IL-2: the first effective immunotherapy for human cancer. J Immunol 192: 5451-8, 2014
SSID ssib058493105
ssj0066718
ssib002671031
ssib002670267
ssib000940189
ssib005879672
Score 2.0606043
SourceID nii
jstage
SourceType Publisher
StartPage 180
Title がん治療を目指すアフェレシス
URI https://www.jstage.jst.go.jp/article/jsao/46/3/46_180/_article/-char/ja
https://cir.nii.ac.jp/crid/1390001204963578752
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 人工臓器, 2017/12/15, Vol.46(3), pp.180-182
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV29b9QwFI_asrAgECAKFHXAC0dKcnHs59E5cqpAICG1UsUS-XKJdFfpDkG7sDUdWDqBGCo2FhbEwIIQf06k9t_gPTu5pgKJj8XyPT87z-9d8n7Pn553l5dhXqJf85UZ5T43YeGrcSl8IwrE95znPKcZ3SdPxeY2f7QT7ywt3--sWtrfG23kr3-7r-R_rIo0tCvtkv0Hyy4aRQLm0b6YooUx_SsbszRCJMhgYDN9piKWCpb0WZKwVDKliNgU9S0lYTolHqwCsqmObI5HO-aIqbilyIai20ckss2oc7gWQ9p57_l8d9JakKUx00OWaHqcGmALPSKhHCSuIlGAnzFzlgADbYXEfNCjnEb-wJZprNVtOQkYDC0LthwQBVKmhr22ISQB0xrLusMabv-m_QueYwSwHcTWkJhaMVFRTplOG1aERPdsZ6xgba8WZVYsVwSkXDJGTMrVYHXxkGlhmQdM6c73N6JN99C4h8L5B4DIF4FbUtw6kGYMddIdX7DeIHSXVDXAInS3LP3qsxCiktN6ZeYbXGwsKp07BZxmHQlNSws4LvSlDGkB6-NnHTCtMFaG7uFxcnG9WPOb7vQ4-_qCVOJs1zQiUYVYfxE8CmQHNwfn1NBuG0FxH3SEReg2xUCGTqhYnk0mHXS2ddm71IRV69q9I1e8pam56t2rD47q6t3J1x-nx1VdvT398OXk6E19cFxXH-vD93X1qT78XFff6ur7NW97mG4NNv3mbhB_SojcH4ncjk2AzGEsw6gMRKnySMSKl2o8FrReIAIzhn4RxQjAirIYcZNDGQZgKAi57q3M5rPihreuCgmFwV6KvORFZMxIxcrIMshFWGL8sOpJ18HshTsAJmte-Iy0kHGRRZSgKhYFtGMym5pVbw01kuUTSlFvdtgXQ3I6AxJk3L_5h_Jb3kV6NdyI321vZe_lfrGGGHhvdMea_ieOcn5J
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E3%81%8C%E3%82%93%E6%B2%BB%E7%99%82%E3%82%92%E7%9B%AE%E6%8C%87%E3%81%99%E3%82%A2%E3%83%95%E3%82%A7%E3%83%AC%E3%82%B7%E3%82%B9&rft.jtitle=Jinko+Zoki&rft.au=%E5%AF%BA%E6%9C%AC+%E5%92%8C%E9%9B%84&rft.au=%E4%B8%8A%E7%94%B0+%E7%A5%90%E4%BA%8C&rft.au=%E5%B0%8F%E7%AC%A0%E5%8E%9F+%E4%B8%80%E8%AA%A0&rft.date=2017&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E4%BA%BA%E5%B7%A5%E8%87%93%E5%99%A8%E5%AD%A6%E4%BC%9A&rft.issn=0300-0818&rft.eissn=1883-6097&rft.volume=46&rft.issue=3&rft.spage=180&rft.epage=182&rft_id=info:doi/10.11392%2Fjsao.46.180&rft.externalDocID=130006507362
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-0818&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-0818&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-0818&client=summon